

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | low-density lipoprotein particle clearance (GO:0034383) | 5.11194276 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 4.69150013 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.69150013 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.69150013 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.69150013 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 4.69150013 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.69150013 |
| 8 | iron ion import (GO:0097286) | 4.30566371 |
| 9 | regulation of cholesterol storage (GO:0010885) | 3.80498499 |
| 10 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.77213021 |
| 11 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.69124454 |
| 12 | response to peptidoglycan (GO:0032494) | 3.59429254 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 3.56174524 |
| 14 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.51271497 |
| 15 | cell adhesion mediated by integrin (GO:0033627) | 3.40369941 |
| 16 | hepatocyte apoptotic process (GO:0097284) | 3.37936033 |
| 17 | protein localization to endosome (GO:0036010) | 3.37252660 |
| 18 | negative regulation of lipid storage (GO:0010888) | 3.31132485 |
| 19 | definitive hemopoiesis (GO:0060216) | 3.30520279 |
| 20 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.28444956 |
| 21 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.25767085 |
| 22 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.25608991 |
| 23 | regulation of integrin activation (GO:0033623) | 3.22902009 |
| 24 | response to thyroid hormone (GO:0097066) | 3.21748609 |
| 25 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.20856746 |
| 26 | NLS-bearing protein import into nucleus (GO:0006607) | 3.19627209 |
| 27 | cellular extravasation (GO:0045123) | 3.19505615 |
| 28 | apoptotic cell clearance (GO:0043277) | 3.19256216 |
| 29 | response to host immune response (GO:0052572) | 3.19186351 |
| 30 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.19186351 |
| 31 | neutrophil activation involved in immune response (GO:0002283) | 3.19170819 |
| 32 | natural killer cell mediated immunity (GO:0002228) | 3.17482846 |
| 33 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.17482846 |
| 34 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.17189981 |
| 35 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.09564409 |
| 36 | positive regulation of p38MAPK cascade (GO:1900745) | 3.05735548 |
| 37 | thrombin receptor signaling pathway (GO:0070493) | 3.04459906 |
| 38 | pore complex assembly (GO:0046931) | 3.02078896 |
| 39 | glycosphingolipid catabolic process (GO:0046479) | 3.00686761 |
| 40 | positive regulation of interferon-alpha production (GO:0032727) | 3.00386027 |
| 41 | plasma lipoprotein particle clearance (GO:0034381) | 2.97318057 |
| 42 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.96545100 |
| 43 | regulation of platelet aggregation (GO:0090330) | 2.96127395 |
| 44 | oligosaccharide catabolic process (GO:0009313) | 2.94326543 |
| 45 | macroautophagy (GO:0016236) | 2.92813785 |
| 46 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.92787129 |
| 47 | wound healing, spreading of epidermal cells (GO:0035313) | 2.92680325 |
| 48 | phospholipid homeostasis (GO:0055091) | 2.91342470 |
| 49 | response to muramyl dipeptide (GO:0032495) | 2.91030922 |
| 50 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.84879972 |
| 51 | response to host (GO:0075136) | 2.84879972 |
| 52 | response to host defenses (GO:0052200) | 2.84879972 |
| 53 | regulation of interferon-alpha production (GO:0032647) | 2.84685699 |
| 54 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.81779487 |
| 55 | negative regulation of cell killing (GO:0031342) | 2.79728491 |
| 56 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.79728491 |
| 57 | Rap protein signal transduction (GO:0032486) | 2.79059373 |
| 58 | I-kappaB phosphorylation (GO:0007252) | 2.76691475 |
| 59 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.76600647 |
| 60 | negative regulation of interleukin-12 production (GO:0032695) | 2.75289035 |
| 61 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.74952101 |
| 62 | glycolipid catabolic process (GO:0019377) | 2.71321846 |
| 63 | positive regulation of lipid storage (GO:0010884) | 2.66974607 |
| 64 | positive regulation of interferon-beta production (GO:0032728) | 2.65233523 |
| 65 | regulation of platelet activation (GO:0010543) | 2.64761209 |
| 66 | regulation of sequestering of triglyceride (GO:0010889) | 2.64053644 |
| 67 | respiratory burst (GO:0045730) | 2.63552082 |
| 68 | alpha-linolenic acid metabolic process (GO:0036109) | 2.63195633 |
| 69 | regulation of macrophage chemotaxis (GO:0010758) | 2.62579023 |
| 70 | positive regulation of leukocyte degranulation (GO:0043302) | 2.62488417 |
| 71 | megakaryocyte development (GO:0035855) | 2.62283511 |
| 72 | regulation of protein polyubiquitination (GO:1902914) | 2.61393988 |
| 73 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.61240492 |
| 74 | negative regulation of interleukin-17 production (GO:0032700) | 2.60642484 |
| 75 | lipoprotein transport (GO:0042953) | 2.58973983 |
| 76 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.57807369 |
| 77 | growth hormone receptor signaling pathway (GO:0060396) | 2.57649977 |
| 78 | detection of molecule of bacterial origin (GO:0032490) | 2.57086151 |
| 79 | regulation of podosome assembly (GO:0071801) | 2.56946268 |
| 80 | positive regulation of receptor recycling (GO:0001921) | 2.56885427 |
| 81 | hypotonic response (GO:0006971) | 2.56494222 |
| 82 | cellular response to arsenic-containing substance (GO:0071243) | 2.56310963 |
| 83 | granulocyte activation (GO:0036230) | 2.55291262 |
| 84 | regulation of mast cell degranulation (GO:0043304) | 2.54676892 |
| 85 | pinocytosis (GO:0006907) | 2.53293576 |
| 86 | regulation of gamma-delta T cell activation (GO:0046643) | 2.53196068 |
| 87 | interferon-gamma secretion (GO:0072643) | 2.53111358 |
| 88 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.52781375 |
| 89 | cellular response to ethanol (GO:0071361) | 2.52529814 |
| 90 | regulation of leukocyte degranulation (GO:0043300) | 2.52135742 |
| 91 | hemidesmosome assembly (GO:0031581) | 2.49526640 |
| 92 | myeloid cell activation involved in immune response (GO:0002275) | 2.48218753 |
| 93 | positive regulation of regulated secretory pathway (GO:1903307) | 2.47653234 |
| 94 | reactive oxygen species biosynthetic process (GO:1903409) | 2.47586566 |
| 95 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.47573861 |
| 96 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.47238973 |
| 97 | immunoglobulin mediated immune response (GO:0016064) | 2.47150283 |
| 98 | regulation of regulated secretory pathway (GO:1903305) | 2.47123360 |
| 99 | cell-substrate junction assembly (GO:0007044) | 2.46900921 |
| 100 | nuclear pore complex assembly (GO:0051292) | 2.46783630 |
| 101 | regulation of cholesterol homeostasis (GO:2000188) | 2.45773759 |
| 102 | regulation of mononuclear cell migration (GO:0071675) | 2.44301579 |
| 103 | regulation of early endosome to late endosome transport (GO:2000641) | 2.43037743 |
| 104 | embryonic process involved in female pregnancy (GO:0060136) | 2.42163213 |
| 105 | regulation of translational termination (GO:0006449) | 2.41848320 |
| 106 | clathrin coat assembly (GO:0048268) | 2.40415493 |
| 107 | import into cell (GO:0098657) | 2.40194038 |
| 108 | regulation of lipid storage (GO:0010883) | 2.39696624 |
| 109 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.39644972 |
| 110 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.38609251 |
| 111 | mannose metabolic process (GO:0006013) | 2.38171101 |
| 112 | nerve growth factor signaling pathway (GO:0038180) | 2.37440593 |
| 113 | neutrophil mediated immunity (GO:0002446) | 2.36839123 |
| 114 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.36455200 |
| 115 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.34964651 |
| 116 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.34784392 |
| 117 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.34038476 |
| 118 | positive regulation of cholesterol transport (GO:0032376) | 2.33538197 |
| 119 | positive regulation of sterol transport (GO:0032373) | 2.33538197 |
| 120 | positive regulation of heat generation (GO:0031652) | 2.33020775 |
| 121 | microglial cell activation (GO:0001774) | 2.32136451 |
| 122 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.31825132 |
| 123 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.31670113 |
| 124 | positive regulation of bone resorption (GO:0045780) | 2.31307540 |
| 125 | positive regulation of bone remodeling (GO:0046852) | 2.31307540 |
| 126 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.30925894 |
| 127 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.30782245 |
| 128 | stress fiber assembly (GO:0043149) | 2.30731748 |
| 129 | peptide catabolic process (GO:0043171) | 2.30586107 |
| 130 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.30347957 |
| 131 | detection of other organism (GO:0098543) | 2.30075398 |
| 132 | neutrophil activation (GO:0042119) | 2.29899555 |
| 133 | urea metabolic process (GO:0019627) | 2.29694375 |
| 134 | urea cycle (GO:0000050) | 2.29694375 |
| 135 | positive regulation of mast cell activation (GO:0033005) | 2.29146918 |
| 136 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.28936298 |
| 137 | cytokine secretion (GO:0050663) | 2.27869455 |
| 138 | cortical actin cytoskeleton organization (GO:0030866) | 2.27512198 |
| 139 | macrophage activation (GO:0042116) | 2.27500649 |
| 140 | sphingosine metabolic process (GO:0006670) | 2.27355038 |
| 141 | germinal center formation (GO:0002467) | 2.27021879 |
| 142 | establishment of endothelial barrier (GO:0061028) | 2.26179470 |
| 143 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.25436120 |
| 144 | modification by symbiont of host morphology or physiology (GO:0044003) | 2.25052690 |
| 145 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.24802753 |
| 146 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.23820960 |
| 147 | adenosine receptor signaling pathway (GO:0001973) | 2.23194437 |
| 148 | positive regulation of lipid catabolic process (GO:0050996) | 2.23154992 |
| 149 | leukocyte mediated cytotoxicity (GO:0001909) | 2.22996473 |
| 150 | regulation of interferon-beta production (GO:0032648) | 2.22625163 |
| 151 | positive regulation of phagocytosis (GO:0050766) | 2.22426124 |
| 152 | osteoclast differentiation (GO:0030316) | 2.21001960 |
| 153 | nuclear pore organization (GO:0006999) | 2.20662991 |
| 154 | * platelet aggregation (GO:0070527) | 2.20367587 |
| 155 | ceramide catabolic process (GO:0046514) | 2.20352630 |
| 156 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.20276863 |
| 157 | regulation of hippo signaling (GO:0035330) | 2.19786117 |
| 158 | myeloid cell development (GO:0061515) | 2.19029140 |
| 159 | regulation of RNA export from nucleus (GO:0046831) | 2.16241699 |
| 160 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.15934537 |
| 161 | leukocyte degranulation (GO:0043299) | 2.15022359 |
| 162 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.14993080 |
| 163 | vesicle coating (GO:0006901) | 2.13908813 |
| 164 | early endosome to late endosome transport (GO:0045022) | 2.13373499 |
| 165 | linoleic acid metabolic process (GO:0043651) | 2.11398353 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.17074285 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.83463691 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.76671777 |
| 4 | GATA1_22025678_ChIP-Seq_K562_Human | 3.41713091 |
| 5 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 3.21463784 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.21421217 |
| 7 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.09945107 |
| 8 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.71975464 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.69686878 |
| 10 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.64808894 |
| 11 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.60353624 |
| 12 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.57471744 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.55208312 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.53389797 |
| 15 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.46045918 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.29872598 |
| 17 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.25714310 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.24846055 |
| 19 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.19333902 |
| 20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.15702873 |
| 21 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.11717839 |
| 22 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.11531479 |
| 23 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.06393134 |
| 24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.03264502 |
| 25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.00642297 |
| 26 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.98495136 |
| 27 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.94173611 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.88838467 |
| 29 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.87905349 |
| 30 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.86324379 |
| 31 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.80588509 |
| 32 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.78706932 |
| 33 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.75097188 |
| 34 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.73441697 |
| 35 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.70377452 |
| 36 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.70275489 |
| 37 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.68755546 |
| 38 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.62867553 |
| 39 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.59880221 |
| 40 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.57651282 |
| 41 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.57317539 |
| 42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.54173671 |
| 43 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.54079124 |
| 44 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.52303956 |
| 45 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.51522095 |
| 46 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.51522095 |
| 47 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.51353029 |
| 48 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.50923017 |
| 49 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.49493178 |
| 50 | ATF3_27146783_Chip-Seq_COLON_Human | 1.49279894 |
| 51 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.49061588 |
| 52 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.46565227 |
| 53 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.46050460 |
| 54 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.45211328 |
| 55 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.44832793 |
| 56 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.44281428 |
| 57 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.43677073 |
| 58 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.43517849 |
| 59 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42577644 |
| 60 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.42240364 |
| 61 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.42210807 |
| 62 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.41690035 |
| 63 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.41070376 |
| 64 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.40055591 |
| 65 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.37195034 |
| 66 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.36666544 |
| 67 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.36395165 |
| 68 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.36218063 |
| 69 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.35787475 |
| 70 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.33648412 |
| 71 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.33093120 |
| 72 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.31087462 |
| 73 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31002436 |
| 74 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.30166402 |
| 75 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.26371978 |
| 76 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.26178017 |
| 77 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.26178017 |
| 78 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.26178017 |
| 79 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.25726793 |
| 80 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.25068491 |
| 81 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.24646704 |
| 82 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24538897 |
| 83 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.24233860 |
| 84 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.23298360 |
| 85 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20816805 |
| 86 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.20641768 |
| 87 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19817533 |
| 88 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.19545406 |
| 89 | GATA1_19941826_ChIP-Seq_K562_Human | 1.18821173 |
| 90 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15884555 |
| 91 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.15043192 |
| 92 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14851295 |
| 93 | MYB_26560356_Chip-Seq_TH2_Human | 1.13723660 |
| 94 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.13210368 |
| 95 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.12727068 |
| 96 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.11897327 |
| 97 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.11434802 |
| 98 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.10829092 |
| 99 | MYC_22102868_ChIP-Seq_BL_Human | 1.09207450 |
| 100 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.07899839 |
| 101 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07622054 |
| 102 | MAF_26560356_Chip-Seq_TH1_Human | 1.06108336 |
| 103 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.06080472 |
| 104 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.06057930 |
| 105 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.05337546 |
| 106 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.05291247 |
| 107 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.05269843 |
| 108 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.03604090 |
| 109 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.03511816 |
| 110 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.03256631 |
| 111 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.02813893 |
| 112 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.01589266 |
| 113 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.01433994 |
| 114 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.01351593 |
| 115 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01233034 |
| 116 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.01181096 |
| 117 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.00192853 |
| 118 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.00163317 |
| 119 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.99694832 |
| 120 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.98263385 |
| 121 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97991502 |
| 122 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.97005505 |
| 123 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.96985160 |
| 124 | KDM2B_26808549_Chip-Seq_K562_Human | 0.96167711 |
| 125 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.95415654 |
| 126 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94856116 |
| 127 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.94463521 |
| 128 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.94017121 |
| 129 | * VDR_24763502_ChIP-Seq_THP-1_Human | 0.93584817 |
| 130 | MYB_26560356_Chip-Seq_TH1_Human | 0.92839469 |
| 131 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.92575863 |
| 132 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.91962092 |
| 133 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.89641685 |
| 134 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.89296535 |
| 135 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89014824 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 3.70232130 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.59898373 |
| 3 | MP0000569_abnormal_digit_pigmentation | 2.91336296 |
| 4 | MP0005076_abnormal_cell_differentiation | 2.89105011 |
| 5 | MP0005058_abnormal_lysosome_morphology | 2.74506658 |
| 6 | MP0003566_abnormal_cell_adhesion | 2.72537195 |
| 7 | MP0010352_gastrointestinal_tract_polyps | 2.71448352 |
| 8 | MP0005451_abnormal_body_composition | 2.67168908 |
| 9 | MP0010234_abnormal_vibrissa_follicle | 2.59743538 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.57863620 |
| 11 | MP0003436_decreased_susceptibility_to | 2.46886293 |
| 12 | MP0009840_abnormal_foam_cell | 2.28936650 |
| 13 | MP0003172_abnormal_lysosome_physiology | 2.28151454 |
| 14 | MP0008057_abnormal_DNA_replication | 2.22604099 |
| 15 | MP0004510_myositis | 2.20041131 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.18295739 |
| 17 | MP0009278_abnormal_bone_marrow | 2.16289604 |
| 18 | MP0004185_abnormal_adipocyte_glucose | 2.13742433 |
| 19 | MP0008004_abnormal_stomach_pH | 2.10028981 |
| 20 | MP0010307_abnormal_tumor_latency | 2.09845008 |
| 21 | MP0005360_urolithiasis | 2.05129579 |
| 22 | MP0004947_skin_inflammation | 1.99448771 |
| 23 | MP0003453_abnormal_keratinocyte_physiol | 1.99330949 |
| 24 | MP0003724_increased_susceptibility_to | 1.97527857 |
| 25 | MP0002796_impaired_skin_barrier | 1.92072034 |
| 26 | MP0002254_reproductive_system_inflammat | 1.83060134 |
| 27 | MP0003183_abnormal_peptide_metabolism | 1.79967612 |
| 28 | MP0002419_abnormal_innate_immunity | 1.78619919 |
| 29 | MP0005409_darkened_coat_color | 1.75096646 |
| 30 | MP0002877_abnormal_melanocyte_morpholog | 1.69427449 |
| 31 | MP0006082_CNS_inflammation | 1.68967179 |
| 32 | MP0004808_abnormal_hematopoietic_stem | 1.67508854 |
| 33 | MP0001545_abnormal_hematopoietic_system | 1.61536201 |
| 34 | MP0005397_hematopoietic_system_phenotyp | 1.61536201 |
| 35 | MP0003828_pulmonary_edema | 1.60489864 |
| 36 | MP0002148_abnormal_hypersensitivity_rea | 1.60371962 |
| 37 | MP0003091_abnormal_cell_migration | 1.56243426 |
| 38 | * MP0003448_altered_tumor_morphology | 1.55478272 |
| 39 | MP0000604_amyloidosis | 1.52769253 |
| 40 | MP0008260_abnormal_autophagy | 1.49221121 |
| 41 | MP0002139_abnormal_hepatobiliary_system | 1.48566553 |
| 42 | MP0010329_abnormal_lipoprotein_level | 1.46070633 |
| 43 | MP0000015_abnormal_ear_pigmentation | 1.45431656 |
| 44 | MP0003656_abnormal_erythrocyte_physiolo | 1.45128354 |
| 45 | * MP0005464_abnormal_platelet_physiology | 1.44900229 |
| 46 | MP0003075_altered_response_to | 1.44808522 |
| 47 | MP0005023_abnormal_wound_healing | 1.38550381 |
| 48 | MP0001835_abnormal_antigen_presentation | 1.38359935 |
| 49 | MP0005167_abnormal_blood-brain_barrier | 1.37555529 |
| 50 | MP0002009_preneoplasia | 1.33880826 |
| 51 | MP0000609_abnormal_liver_physiology | 1.31497121 |
| 52 | MP0004130_abnormal_muscle_cell | 1.29096742 |
| 53 | MP0005666_abnormal_adipose_tissue | 1.28425250 |
| 54 | MP0002396_abnormal_hematopoietic_system | 1.26843710 |
| 55 | MP0004147_increased_porphyrin_level | 1.25826591 |
| 56 | MP0000858_altered_metastatic_potential | 1.25384072 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.24141764 |
| 58 | MP0001851_eye_inflammation | 1.21419860 |
| 59 | MP0002006_tumorigenesis | 1.21105454 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 1.20893518 |
| 61 | MP0005025_abnormal_response_to | 1.18473171 |
| 62 | MP0005365_abnormal_bile_salt | 1.17562742 |
| 63 | MP0003950_abnormal_plasma_membrane | 1.16946055 |
| 64 | MP0005085_abnormal_gallbladder_physiolo | 1.16791801 |
| 65 | MP0001853_heart_inflammation | 1.16712366 |
| 66 | MP0002166_altered_tumor_susceptibility | 1.16358031 |
| 67 | MP0008875_abnormal_xenobiotic_pharmacok | 1.14564393 |
| 68 | MP0001216_abnormal_epidermal_layer | 1.14415514 |
| 69 | MP0010155_abnormal_intestine_physiology | 1.14399836 |
| 70 | MP0000465_gastrointestinal_hemorrhage | 1.13767262 |
| 71 | MP0004233_abnormal_muscle_weight | 1.12860349 |
| 72 | MP0003806_abnormal_nucleotide_metabolis | 1.12216863 |
| 73 | MP0003690_abnormal_glial_cell | 1.10327538 |
| 74 | MP0000343_altered_response_to | 1.10315741 |
| 75 | MP0004264_abnormal_extraembryonic_tissu | 1.10171430 |
| 76 | MP0005408_hypopigmentation | 1.09131251 |
| 77 | MP0009764_decreased_sensitivity_to | 1.09041191 |
| 78 | MP0005257_abnormal_intraocular_pressure | 1.08201241 |
| 79 | MP0002452_abnormal_antigen_presenting | 1.07805051 |
| 80 | MP0009785_altered_susceptibility_to | 1.06611845 |
| 81 | MP0005501_abnormal_skin_physiology | 1.06033288 |
| 82 | MP0005000_abnormal_immune_tolerance | 1.05634899 |
| 83 | MP0004484_altered_response_of | 1.02766410 |
| 84 | MP0005083_abnormal_biliary_tract | 1.01029943 |
| 85 | MP0002398_abnormal_bone_marrow | 1.00330146 |
| 86 | MP0001881_abnormal_mammary_gland | 1.00321475 |
| 87 | MP0000383_abnormal_hair_follicle | 1.00071911 |
| 88 | MP0001845_abnormal_inflammatory_respons | 0.98961889 |
| 89 | MP0002405_respiratory_system_inflammati | 0.96002053 |
| 90 | MP0002086_abnormal_extraembryonic_tissu | 0.95468451 |
| 91 | MP0000627_abnormal_mammary_gland | 0.94531711 |
| 92 | MP0000371_diluted_coat_color | 0.93774487 |
| 93 | MP0003252_abnormal_bile_duct | 0.93587429 |
| 94 | MP0005310_abnormal_salivary_gland | 0.93023446 |
| 95 | MP0008469_abnormal_protein_level | 0.92276933 |
| 96 | MP0009697_abnormal_copulation | 0.92119535 |
| 97 | MP0005670_abnormal_white_adipose | 0.90541731 |
| 98 | MP0005166_decreased_susceptibility_to | 0.89018277 |
| 99 | MP0001915_intracranial_hemorrhage | 0.88930387 |
| 100 | MP0004381_abnormal_hair_follicle | 0.88888809 |
| 101 | MP0002723_abnormal_immune_serum | 0.87428521 |
| 102 | MP0001790_abnormal_immune_system | 0.87354354 |
| 103 | MP0005387_immune_system_phenotype | 0.87354354 |
| 104 | MP0005319_abnormal_enzyme/_coenzyme | 0.87147942 |
| 105 | MP0003221_abnormal_cardiomyocyte_apopto | 0.87041513 |
| 106 | MP0000685_abnormal_immune_system | 0.85771210 |
| 107 | MP0005375_adipose_tissue_phenotype | 0.85239187 |
| 108 | * MP0005621_abnormal_cell_physiology | 0.85105320 |
| 109 | MP0002060_abnormal_skin_morphology | 0.84381702 |
| 110 | MP0002420_abnormal_adaptive_immunity | 0.83825105 |
| 111 | MP0005164_abnormal_response_to | 0.83242539 |
| 112 | MP0009763_increased_sensitivity_to | 0.82010329 |
| 113 | MP0004858_abnormal_nervous_system | 0.81695288 |
| 114 | MP0005165_increased_susceptibility_to | 0.81259095 |
| 115 | MP0005174_abnormal_tail_pigmentation | 0.80673255 |
| 116 | MP0009115_abnormal_fat_cell | 0.80663764 |
| 117 | * MP0002118_abnormal_lipid_homeostasis | 0.80282175 |
| 118 | MP0001849_ear_inflammation | 0.79961075 |
| 119 | MP0001800_abnormal_humoral_immune | 0.79092165 |
| 120 | MP0000920_abnormal_myelination | 0.79063761 |
| 121 | MP0010678_abnormal_skin_adnexa | 0.79061419 |
| 122 | MP0005647_abnormal_sex_gland | 0.78618693 |
| 123 | MP0000598_abnormal_liver_morphology | 0.77451908 |
| 124 | MP0002332_abnormal_exercise_endurance | 0.76669995 |
| 125 | MP0001191_abnormal_skin_condition | 0.76146243 |
| 126 | MP0001819_abnormal_immune_cell | 0.76019028 |
| 127 | MP0002971_abnormal_brown_adipose | 0.75923733 |
| 128 | MP0002998_abnormal_bone_remodeling | 0.74147016 |
| 129 | MP0002429_abnormal_blood_cell | 0.74139297 |
| 130 | MP0002088_abnormal_embryonic_growth/wei | 0.73928472 |
| 131 | MP0004019_abnormal_vitamin_homeostasis | 0.73912685 |
| 132 | MP0000689_abnormal_spleen_morphology | 0.73806536 |
| 133 | * MP0005384_cellular_phenotype | 0.73488987 |
| 134 | MP0000716_abnormal_immune_system | 0.73233533 |
| 135 | MP0004883_abnormal_blood_vessel | 0.72741079 |
| 136 | MP0003984_embryonic_growth_retardation | 0.72452752 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.53576282 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.49295529 |
| 3 | Prolonged bleeding time (HP:0003010) | 4.46823645 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.27450080 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.13834065 |
| 6 | Petechiae (HP:0000967) | 3.79732565 |
| 7 | Myocardial infarction (HP:0001658) | 3.71073094 |
| 8 | Increased cerebral lipofuscin (HP:0011813) | 3.70022536 |
| 9 | Menorrhagia (HP:0000132) | 3.57152787 |
| 10 | Gingival bleeding (HP:0000225) | 3.40594015 |
| 11 | Abnormality of macrophages (HP:0004311) | 3.33824779 |
| 12 | Epistaxis (HP:0000421) | 3.29993447 |
| 13 | Axonal loss (HP:0003447) | 3.08232345 |
| 14 | Global brain atrophy (HP:0002283) | 3.03779793 |
| 15 | Purpura (HP:0000979) | 2.99690880 |
| 16 | Papillary thyroid carcinoma (HP:0002895) | 2.90429900 |
| 17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.85143661 |
| 18 | Autoimmune thrombocytopenia (HP:0001973) | 2.78961286 |
| 19 | Abnormal platelet function (HP:0011869) | 2.74655437 |
| 20 | Impaired platelet aggregation (HP:0003540) | 2.74655437 |
| 21 | Gingivitis (HP:0000230) | 2.72997893 |
| 22 | Thick nail (HP:0001805) | 2.70444246 |
| 23 | Acanthocytosis (HP:0001927) | 2.69309649 |
| 24 | Acute myeloid leukemia (HP:0004808) | 2.69129703 |
| 25 | Osteolytic defects of the hand bones (HP:0009699) | 2.68630323 |
| 26 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.68630323 |
| 27 | Hematochezia (HP:0002573) | 2.66643539 |
| 28 | Disinhibition (HP:0000734) | 2.65945147 |
| 29 | Termporal pattern (HP:0011008) | 2.60334819 |
| 30 | Insidious onset (HP:0003587) | 2.60334819 |
| 31 | Dysmetric saccades (HP:0000641) | 2.59882219 |
| 32 | Systemic lupus erythematosus (HP:0002725) | 2.58566739 |
| 33 | Upper motor neuron abnormality (HP:0002127) | 2.51194325 |
| 34 | Curly hair (HP:0002212) | 2.49107215 |
| 35 | Mediastinal lymphadenopathy (HP:0100721) | 2.46902521 |
| 36 | Esophageal varix (HP:0002040) | 2.46368432 |
| 37 | Autoimmune hemolytic anemia (HP:0001890) | 2.46131769 |
| 38 | Vacuolated lymphocytes (HP:0001922) | 2.45527631 |
| 39 | Macroorchidism (HP:0000053) | 2.45153763 |
| 40 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.43723972 |
| 41 | Mucopolysacchariduria (HP:0008155) | 2.43723972 |
| 42 | Spontaneous hematomas (HP:0007420) | 2.42639928 |
| 43 | Frequent falls (HP:0002359) | 2.41210620 |
| 44 | Poikilocytosis (HP:0004447) | 2.39612606 |
| 45 | Slow saccadic eye movements (HP:0000514) | 2.39510832 |
| 46 | Prostate neoplasm (HP:0100787) | 2.39433073 |
| 47 | Dysostosis multiplex (HP:0000943) | 2.38965648 |
| 48 | Xanthomatosis (HP:0000991) | 2.38710030 |
| 49 | Pustule (HP:0200039) | 2.35417390 |
| 50 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.34851492 |
| 51 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.34851492 |
| 52 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.34851492 |
| 53 | Hand muscle atrophy (HP:0009130) | 2.32831860 |
| 54 | Ankyloglossia (HP:0010296) | 2.32262336 |
| 55 | Cerebral aneurysm (HP:0004944) | 2.31033588 |
| 56 | Tetraparesis (HP:0002273) | 2.28956482 |
| 57 | Abnormality of the common coagulation pathway (HP:0010990) | 2.28105659 |
| 58 | Amyloidosis (HP:0011034) | 2.27497188 |
| 59 | Abnormal large intestine physiology (HP:0012700) | 2.27365176 |
| 60 | Distal upper limb amyotrophy (HP:0007149) | 2.27345929 |
| 61 | Upper limb amyotrophy (HP:0009129) | 2.27345929 |
| 62 | Hydroxyprolinuria (HP:0003080) | 2.27205683 |
| 63 | Abnormality of proline metabolism (HP:0010907) | 2.27205683 |
| 64 | Abnormality of the Achilles tendon (HP:0005109) | 2.27171308 |
| 65 | Cerebral inclusion bodies (HP:0100314) | 2.25960342 |
| 66 | Increased mean platelet volume (HP:0011877) | 2.24783752 |
| 67 | Achilles tendon contracture (HP:0001771) | 2.23697067 |
| 68 | Deep venous thrombosis (HP:0002625) | 2.22640772 |
| 69 | Abnormality of glycolipid metabolism (HP:0010969) | 2.20027184 |
| 70 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.20027184 |
| 71 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.20027184 |
| 72 | Bowel incontinence (HP:0002607) | 2.15655597 |
| 73 | Recurrent skin infections (HP:0001581) | 2.15299799 |
| 74 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.14698865 |
| 75 | Complement deficiency (HP:0004431) | 2.13813474 |
| 76 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.08428063 |
| 77 | Cortical dysplasia (HP:0002539) | 2.06929614 |
| 78 | Nephritis (HP:0000123) | 2.05574860 |
| 79 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 2.04682834 |
| 80 | Urticaria (HP:0001025) | 2.04668848 |
| 81 | Recurrent fungal infections (HP:0002841) | 2.04495289 |
| 82 | Neurofibrillary tangles (HP:0002185) | 2.03823530 |
| 83 | Thyroid carcinoma (HP:0002890) | 2.02928484 |
| 84 | Epidermoid cyst (HP:0200040) | 2.02543707 |
| 85 | Abnormal platelet volume (HP:0011876) | 2.01798503 |
| 86 | Interstitial pulmonary disease (HP:0006530) | 2.01747126 |
| 87 | Abnormality of complement system (HP:0005339) | 2.01623169 |
| 88 | Increased CSF protein (HP:0002922) | 2.01412846 |
| 89 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.01032238 |
| 90 | Conjunctival telangiectasia (HP:0000524) | 2.01013709 |
| 91 | Periodontitis (HP:0000704) | 2.01008813 |
| 92 | Peripheral demyelination (HP:0011096) | 2.00238178 |
| 93 | Subacute progressive viral hepatitis (HP:0006572) | 1.99290463 |
| 94 | Uterine leiomyosarcoma (HP:0002891) | 1.97709758 |
| 95 | Leiomyosarcoma (HP:0100243) | 1.97709758 |
| 96 | Obstructive lung disease (HP:0006536) | 1.97506133 |
| 97 | Chronic obstructive pulmonary disease (HP:0006510) | 1.97506133 |
| 98 | Bladder neoplasm (HP:0009725) | 1.96465073 |
| 99 | Bladder carcinoma (HP:0002862) | 1.96465073 |
| 100 | Right ventricular cardiomyopathy (HP:0011663) | 1.95892091 |
| 101 | Pathologic fracture (HP:0002756) | 1.95536504 |
| 102 | Stomatitis (HP:0010280) | 1.95018802 |
| 103 | Spastic tetraparesis (HP:0001285) | 1.94723636 |
| 104 | Abnormality of saccadic eye movements (HP:0000570) | 1.92576370 |
| 105 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.92145121 |
| 106 | Hemorrhage of the eye (HP:0011885) | 1.90615178 |
| 107 | Orchitis (HP:0100796) | 1.90476750 |
| 108 | Neuronal loss in central nervous system (HP:0002529) | 1.88938160 |
| 109 | Abnormality of the fingertips (HP:0001211) | 1.88016174 |
| 110 | Increased connective tissue (HP:0009025) | 1.87001686 |
| 111 | Spastic diplegia (HP:0001264) | 1.85231845 |
| 112 | Reticulocytosis (HP:0001923) | 1.85162982 |
| 113 | Glomerulonephritis (HP:0000099) | 1.84781454 |
| 114 | Alopecia of scalp (HP:0002293) | 1.81331301 |
| 115 | Abnormality of iron homeostasis (HP:0011031) | 1.80017516 |
| 116 | Deep philtrum (HP:0002002) | 1.79518519 |
| 117 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.78752473 |
| 118 | Increased serum ferritin (HP:0003281) | 1.78554211 |
| 119 | Biliary tract neoplasm (HP:0100574) | 1.77989729 |
| 120 | Bone pain (HP:0002653) | 1.77947688 |
| 121 | Ocular albinism (HP:0001107) | 1.77803317 |
| 122 | Urethral obstruction (HP:0000796) | 1.76533151 |
| 123 | Agnosia (HP:0010524) | 1.75958972 |
| 124 | Hypercholesterolemia (HP:0003124) | 1.75343312 |
| 125 | Hyperthyroidism (HP:0000836) | 1.75012691 |
| 126 | Amaurosis fugax (HP:0100576) | 1.74028014 |
| 127 | Decreased motor nerve conduction velocity (HP:0003431) | 1.73867549 |
| 128 | Autoamputation (HP:0001218) | 1.73516041 |
| 129 | Myositis (HP:0100614) | 1.72469712 |
| 130 | Cerebral hemorrhage (HP:0001342) | 1.72454200 |
| 131 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.72278252 |
| 132 | Postural tremor (HP:0002174) | 1.70931524 |
| 133 | Sensorimotor neuropathy (HP:0007141) | 1.70132547 |
| 134 | Fatigue (HP:0012378) | 1.70010885 |
| 135 | Cholecystitis (HP:0001082) | 1.70007442 |
| 136 | Abnormal gallbladder physiology (HP:0012438) | 1.70007442 |
| 137 | Acanthosis nigricans (HP:0000956) | 1.69970329 |
| 138 | Abnormality of oral frenula (HP:0000190) | 1.69508009 |
| 139 | Polycythemia (HP:0001901) | 1.69181436 |
| 140 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.69091633 |
| 141 | Coarse hair (HP:0002208) | 1.68829073 |
| 142 | Flat acetabular roof (HP:0003180) | 1.68826746 |
| 143 | Ulnar bowing (HP:0003031) | 1.67973945 |
| 144 | Viral hepatitis (HP:0006562) | 1.66202401 |
| 145 | Joint hemorrhage (HP:0005261) | 1.65696114 |
| 146 | Hypoalphalipoproteinemia (HP:0003233) | 1.64707341 |
| 147 | Gastrointestinal carcinoma (HP:0002672) | 1.64341653 |
| 148 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.64341653 |
| 149 | Oligodontia (HP:0000677) | 1.63898680 |
| 150 | Dyschromatopsia (HP:0007641) | 1.63889938 |
| 151 | Turricephaly (HP:0000262) | 1.63469230 |
| 152 | Loss of speech (HP:0002371) | 1.63187209 |
| 153 | Hyporeflexia of lower limbs (HP:0002600) | 1.63115073 |
| 154 | Abnormality of the lumbar spine (HP:0100712) | 1.62070210 |
| 155 | Scanning speech (HP:0002168) | 1.62030542 |
| 156 | Spinal muscular atrophy (HP:0007269) | 1.62025943 |
| 157 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.61940505 |
| 158 | Ventricular fibrillation (HP:0001663) | 1.61384913 |
| 159 | Osteomyelitis (HP:0002754) | 1.60435771 |
| 160 | Resting tremor (HP:0002322) | 1.58581529 |
| 161 | Bundle branch block (HP:0011710) | 1.57694047 |
| 162 | Personality changes (HP:0000751) | 1.56477695 |
| 163 | Skin nodule (HP:0200036) | 1.56169750 |
| 164 | Arterial thrombosis (HP:0004420) | 1.55964146 |
| 165 | Paralysis (HP:0003470) | 1.55879121 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 3.44548377 |
| 2 | RIPK4 | 3.07766473 |
| 3 | BMPR2 | 3.04949543 |
| 4 | MST4 | 2.96665412 |
| 5 | CAMK1D | 2.82542954 |
| 6 | TRIB3 | 2.53826438 |
| 7 | EIF2AK1 | 2.41673805 |
| 8 | MAP3K9 | 2.32334849 |
| 9 | EPHA2 | 2.22444730 |
| 10 | KSR2 | 2.02085100 |
| 11 | MAP3K14 | 2.01181298 |
| 12 | TTN | 1.92757582 |
| 13 | LATS1 | 1.88433377 |
| 14 | ERN1 | 1.86927007 |
| 15 | SCYL2 | 1.86833526 |
| 16 | CAMK1G | 1.85102937 |
| 17 | PKN2 | 1.84569249 |
| 18 | PRPF4B | 1.77394706 |
| 19 | LATS2 | 1.77319742 |
| 20 | STK10 | 1.76734401 |
| 21 | TBK1 | 1.65136104 |
| 22 | CDK6 | 1.63409939 |
| 23 | MAP3K1 | 1.61444286 |
| 24 | TYK2 | 1.61070581 |
| 25 | ALK | 1.58615259 |
| 26 | AKT3 | 1.56158226 |
| 27 | BMX | 1.55828264 |
| 28 | RIPK1 | 1.52602978 |
| 29 | STK3 | 1.51717552 |
| 30 | PTK6 | 1.49402204 |
| 31 | IRAK3 | 1.41428480 |
| 32 | MAP3K2 | 1.39286500 |
| 33 | MAP2K3 | 1.38098822 |
| 34 | CSK | 1.34974628 |
| 35 | FGR | 1.34168094 |
| 36 | MAP3K3 | 1.33686452 |
| 37 | IRAK2 | 1.32639559 |
| 38 | EEF2K | 1.28478791 |
| 39 | RPS6KA4 | 1.28128241 |
| 40 | ACVR1B | 1.26907698 |
| 41 | YES1 | 1.25972604 |
| 42 | SIK3 | 1.18421153 |
| 43 | MAP3K13 | 1.18012004 |
| 44 | SIK1 | 1.16716562 |
| 45 | JAK1 | 1.16437166 |
| 46 | BRSK2 | 1.15903067 |
| 47 | ZAP70 | 1.15573233 |
| 48 | PBK | 1.15090903 |
| 49 | EPHB1 | 1.13864837 |
| 50 | IRAK1 | 1.09204139 |
| 51 | ICK | 1.08629330 |
| 52 | PTK2 | 1.06949468 |
| 53 | TAOK1 | 1.03497010 |
| 54 | MTOR | 1.02920159 |
| 55 | NEK9 | 1.02547787 |
| 56 | STK38 | 1.01769442 |
| 57 | NEK1 | 1.00708197 |
| 58 | ABL2 | 0.99855576 |
| 59 | JAK2 | 0.97121197 |
| 60 | TAOK3 | 0.96553671 |
| 61 | DAPK2 | 0.96241837 |
| 62 | NEK6 | 0.96059735 |
| 63 | LRRK2 | 0.95878677 |
| 64 | MAP3K12 | 0.95232222 |
| 65 | PAK4 | 0.94493475 |
| 66 | MAP3K8 | 0.92643840 |
| 67 | PDK2 | 0.90780628 |
| 68 | TGFBR2 | 0.90415444 |
| 69 | IKBKB | 0.90150376 |
| 70 | EIF2AK3 | 0.90060707 |
| 71 | TEC | 0.89961207 |
| 72 | FRK | 0.89546690 |
| 73 | RAF1 | 0.88714898 |
| 74 | MAP3K5 | 0.88454373 |
| 75 | TAOK2 | 0.87709197 |
| 76 | EGFR | 0.86076104 |
| 77 | CAMKK1 | 0.84726214 |
| 78 | HCK | 0.83671797 |
| 79 | TRPM7 | 0.81376034 |
| 80 | CSF1R | 0.79813451 |
| 81 | MARK3 | 0.79433449 |
| 82 | RPS6KB2 | 0.79369101 |
| 83 | CHUK | 0.79276556 |
| 84 | MST1R | 0.79032845 |
| 85 | BTK | 0.76839165 |
| 86 | PNCK | 0.75758443 |
| 87 | ERBB4 | 0.75558009 |
| 88 | PIM1 | 0.75184142 |
| 89 | MAP3K6 | 0.73824751 |
| 90 | NEK2 | 0.73578696 |
| 91 | WNK1 | 0.70121811 |
| 92 | SYK | 0.70011271 |
| 93 | PDGFRB | 0.69739918 |
| 94 | CDK4 | 0.69169435 |
| 95 | SGK2 | 0.68958558 |
| 96 | FER | 0.68749935 |
| 97 | MATK | 0.68608188 |
| 98 | PDPK1 | 0.67667047 |
| 99 | KSR1 | 0.67597755 |
| 100 | NTRK1 | 0.65066954 |
| 101 | NTRK3 | 0.64447410 |
| 102 | PAK6 | 0.62107649 |
| 103 | ABL1 | 0.61838297 |
| 104 | BLK | 0.60627651 |
| 105 | RET | 0.60098861 |
| 106 | PDGFRA | 0.60082337 |
| 107 | IRAK4 | 0.60030606 |
| 108 | DMPK | 0.59882208 |
| 109 | JAK3 | 0.57743475 |
| 110 | PRKG2 | 0.57367984 |
| 111 | STK24 | 0.55966490 |
| 112 | GSK3A | 0.55691338 |
| 113 | MET | 0.55413924 |
| 114 | KIT | 0.53746905 |
| 115 | PRKAA2 | 0.52651001 |
| 116 | IKBKE | 0.52503979 |
| 117 | PIK3CG | 0.51888160 |
| 118 | MELK | 0.50077216 |
| 119 | SGK3 | 0.48177439 |
| 120 | STK4 | 0.47978434 |
| 121 | PDK1 | 0.47673244 |
| 122 | MAP2K1 | 0.47154220 |
| 123 | MAP3K11 | 0.47052867 |
| 124 | FGFR3 | 0.46797446 |
| 125 | SIK2 | 0.46432405 |
| 126 | STK11 | 0.44072739 |
| 127 | FES | 0.43808870 |
| 128 | PTK2B | 0.43365259 |
| 129 | MAPKAPK3 | 0.43316882 |
| 130 | WEE1 | 0.41711171 |
| 131 | MAP2K4 | 0.41090345 |
| 132 | FGFR4 | 0.40219473 |
| 133 | GRK6 | 0.39696518 |
| 134 | SGK1 | 0.37206985 |
| 135 | MAPK10 | 0.36993932 |
| 136 | SMG1 | 0.36697650 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.81542290 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.53578111 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.27289211 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.90968169 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.85986000 |
| 6 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 1.82361714 |
| 7 | Lysosome_Homo sapiens_hsa04142 | 1.78758412 |
| 8 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.66655179 |
| 9 | Tuberculosis_Homo sapiens_hsa05152 | 1.66488901 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.58835858 |
| 11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.53898985 |
| 12 | Pertussis_Homo sapiens_hsa05133 | 1.50617672 |
| 13 | Long-term potentiation_Homo sapiens_hsa04720 | 1.46794011 |
| 14 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.44770759 |
| 15 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.44150965 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.41617846 |
| 17 | * Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.41388120 |
| 18 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.37285687 |
| 19 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.36776903 |
| 20 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.36255964 |
| 21 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.31606109 |
| 22 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.29792096 |
| 23 | Thyroid cancer_Homo sapiens_hsa05216 | 1.29505856 |
| 24 | * Amoebiasis_Homo sapiens_hsa05146 | 1.25602452 |
| 25 | * Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.24894258 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.24320990 |
| 27 | Legionellosis_Homo sapiens_hsa05134 | 1.23342188 |
| 28 | Shigellosis_Homo sapiens_hsa05131 | 1.23034665 |
| 29 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.22718854 |
| 30 | Phagosome_Homo sapiens_hsa04145 | 1.21611904 |
| 31 | * Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.17349661 |
| 32 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.15966060 |
| 33 | * mTOR signaling pathway_Homo sapiens_hsa04150 | 1.15777723 |
| 34 | * ErbB signaling pathway_Homo sapiens_hsa04012 | 1.15750950 |
| 35 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.15094990 |
| 36 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.14702872 |
| 37 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.14204860 |
| 38 | * TNF signaling pathway_Homo sapiens_hsa04668 | 1.13415159 |
| 39 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.11371700 |
| 40 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.11329183 |
| 41 | * Apoptosis_Homo sapiens_hsa04210 | 1.11079968 |
| 42 | Adherens junction_Homo sapiens_hsa04520 | 1.10774219 |
| 43 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.10763281 |
| 44 | * Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.08536528 |
| 45 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.06742789 |
| 46 | * Endometrial cancer_Homo sapiens_hsa05213 | 1.05898041 |
| 47 | * Small cell lung cancer_Homo sapiens_hsa05222 | 1.04777736 |
| 48 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.00131119 |
| 49 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.00011369 |
| 50 | Salmonella infection_Homo sapiens_hsa05132 | 0.98889545 |
| 51 | Bladder cancer_Homo sapiens_hsa05219 | 0.97442766 |
| 52 | Malaria_Homo sapiens_hsa05144 | 0.96943146 |
| 53 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.95729174 |
| 54 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.94538201 |
| 55 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.93110316 |
| 56 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.91918252 |
| 57 | * Influenza A_Homo sapiens_hsa05164 | 0.91093948 |
| 58 | * Insulin resistance_Homo sapiens_hsa04931 | 0.89384829 |
| 59 | * Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.85720081 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.85083131 |
| 61 | * Pancreatic cancer_Homo sapiens_hsa05212 | 0.83675530 |
| 62 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83596611 |
| 63 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.83049984 |
| 64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.82450316 |
| 65 | * Hepatitis B_Homo sapiens_hsa05161 | 0.80927063 |
| 66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.80747239 |
| 67 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80451884 |
| 68 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.79634666 |
| 69 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.79099740 |
| 70 | * Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.79037374 |
| 71 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.79033841 |
| 72 | * Measles_Homo sapiens_hsa05162 | 0.77840149 |
| 73 | * VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77420223 |
| 74 | * Renal cell carcinoma_Homo sapiens_hsa05211 | 0.76962257 |
| 75 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.76895381 |
| 76 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76687566 |
| 77 | * Hepatitis C_Homo sapiens_hsa05160 | 0.76476659 |
| 78 | * Glioma_Homo sapiens_hsa05214 | 0.74028002 |
| 79 | * Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.73883478 |
| 80 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.71955563 |
| 81 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.70202592 |
| 82 | * Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.70064689 |
| 83 | Endocytosis_Homo sapiens_hsa04144 | 0.69899874 |
| 84 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.69735292 |
| 85 | Long-term depression_Homo sapiens_hsa04730 | 0.67948577 |
| 86 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.67054658 |
| 87 | Bile secretion_Homo sapiens_hsa04976 | 0.66755094 |
| 88 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.66330744 |
| 89 | * Focal adhesion_Homo sapiens_hsa04510 | 0.66286434 |
| 90 | * Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65751321 |
| 91 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64868033 |
| 92 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.64858751 |
| 93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.64443711 |
| 94 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63971886 |
| 95 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.61901378 |
| 96 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.60403631 |
| 97 | * Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59662660 |
| 98 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.59224353 |
| 99 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.58392333 |
| 100 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.57908213 |
| 101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.57712741 |
| 102 | * Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56920384 |
| 103 | * HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56421689 |
| 104 | * Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55966258 |
| 105 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.55545705 |
| 106 | Prion diseases_Homo sapiens_hsa05020 | 0.55154625 |
| 107 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.54662976 |
| 108 | * Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.53572372 |
| 109 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53254118 |
| 110 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.52697330 |
| 111 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52602778 |
| 112 | Gap junction_Homo sapiens_hsa04540 | 0.52394162 |
| 113 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.51721162 |
| 114 | * Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51635824 |
| 115 | * Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.51123906 |
| 116 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.51079105 |
| 117 | * Platelet activation_Homo sapiens_hsa04611 | 0.49828271 |
| 118 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.48907760 |
| 119 | Viral myocarditis_Homo sapiens_hsa05416 | 0.48857733 |
| 120 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.48645704 |
| 121 | * Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47887448 |
| 122 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.47463952 |
| 123 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.47042238 |
| 124 | Mineral absorption_Homo sapiens_hsa04978 | 0.46847690 |
| 125 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.46097193 |
| 126 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.45660396 |
| 127 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44724512 |
| 128 | * Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.44664170 |
| 129 | * Prostate cancer_Homo sapiens_hsa05215 | 0.44106939 |
| 130 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.42966152 |
| 131 | Other glycan degradation_Homo sapiens_hsa00511 | 0.42811694 |
| 132 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.42728712 |

